NCT02838758View on ClinicalTrials.gov

Compare Ultrasound Assisted Cold Therapy and Lidocaine Injection to Treat Morton's Neuroma

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

June 1, 2018

Study Completion Date

June 1, 2018

Conditions
Intermetatarsal Neuroma
Interventions
DEVICE

Cryoablation

A minimally invasive cryoablation device. It delivers focused nitrous oxide to the target tissue via a 22-gauge needle to create an approximately 9.4mm by 5.4mm spherical freezing zone of temperature between -20 to -100° C.

DRUG

Lidocaine

Roughly 3cc of lidocaine will be injected near the intermetatarsal neuroma under ultrasound visualization.

DRUG

Saline

Roughly 3cc of saline will be injected near the intermetatarsal neuroma under ultrasound visualization.

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT02838758 - Compare Ultrasound Assisted Cold Therapy and Lidocaine Injection to Treat Morton's Neuroma | Biotech Hunter | Biotech Hunter